tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 207 are a BUY (94.95%), 5 are a SELL (2.29%), 6 are a HOLD (2.75%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 46.52% that have a potential upside of 44.46% achieved within 186 days.
Leland Gershell’s has documented 460 price targets and ratings displayed on 53 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CAPR, Capricor Therapeutics at 08-Dec-2025.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/23/2024. The price target of $15 was fulfilled within 7 days with a profit of $9.03 (151.26%) receiving and performance score of 216.08.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 12-Jul-2023
$12
$8.63 (256.08%)
$12
1 years 3 months 12 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy
$2.5
$-0.28 (-10.07%)
2 years 10 months 23 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
Since 22-Dec-2021
$30
3 years 6 months 16 days ago
(22-Jun-2022)
0/2 (0%)
$22.32 (290.63%)
Hold
Since 02-Sep-2020
$12
$8.63 (256.08%)
5 years 4 months 5 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Buy
Since 31-Aug-2020
5 years 4 months 7 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?
